Advisor Net Financial, Inc Myriad Genetics Inc Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$13.91 - $21.32 $153 - $234	11 Added 1100.0%	12 $0
Q3 2023 Oct 12, 2023	SELL	$15.99 - $23.22 $143 - $208	-9 Reduced 90.0%	1 $0
Q2 2023 Jul 14, 2023	BUY	$17.56 - $23.76 $35 - $47	2 Added 25.0%	10 $0
Q1 2023 Apr 28, 2023	BUY	$15.26 - $23.75 $122 - $190	8 New	8 $0
Q4 2018 Feb 08, 2019	SELL	$27.23 - $45.56 $435 - $728	-16 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $601 - $805	16 New	16 $1,000

230

88.9M

43.5K

18.1K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.